AJOONI
Ajooni Biotech Limited
Cattle feed for dairy and livestock customers
Fast Moving Consumer Goods›Fast Moving Consumer Goods›Food Products›Animal Feed
ajoonibiotech.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Ajooni Biotech Limited makes cattle feed and sells it to customers in India and abroad.
Company snapshot
5thBy market cap
Ranked among 5 companies in Animal Feed.
What we see
- ✓Debt-to-equity of 0.19x — the company is largely funded by its own money, not borrowed funds.
- ✗Net margin is very thin at 2.4% — little room for error if costs rise.
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19 Cr | 20 Cr | 20 Cr | 26 Cr | 26 Cr | 34 Cr | 29 Cr | 31 Cr | 32 Cr | 59 Cr | 61 Cr | 63 Cr |
| Operating expenses (approx.) | 19 Cr | 21 Cr | 18 Cr | 25 Cr | 25 Cr | 33 Cr | 28 Cr | 31 Cr | 30 Cr | 56 Cr | 60 Cr | 62 Cr |
| EBITDA | 0.64 Cr | -0.66 Cr | 2 Cr | 0.96 Cr | 0.77 Cr | 0.93 Cr | 1 Cr | 0.71 Cr | 2 Cr | 3 Cr | 1 Cr | 2 Cr |
| OPM % | 3.3% | -3.3% | 8.1% | 3.8% | 3.0% | 2.7% | 3.5% | 2.3% | 4.7% | 5.2% | 1.7% | 2.6% |
| Other income | 0.29 Cr | 2 Cr | 0.26 Cr | 0.04 Cr | 0.31 Cr | 0.39 Cr | 1 Cr | 0.65 Cr | 0.15 Cr | 0.32 Cr | 1 Cr | 0.27 Cr |
| Interest | 0.19 Cr | 0.12 Cr | 0.11 Cr | 0.15 Cr | 0.06 Cr | 0.07 Cr | 0.06 Cr | 0.08 Cr | 0.17 Cr | 0.18 Cr | 0.29 Cr | 0.48 Cr |
| Depreciation | 0.21 Cr | 0.21 Cr | 0.24 Cr | 0.22 Cr | 0.23 Cr | 0.24 Cr | 0.38 Cr | 0.25 Cr | 0.25 Cr | 0.81 Cr | 0.90 Cr | 0.80 Cr |
| Profit before tax | 0.52 Cr | 0.58 Cr | 1 Cr | 0.63 Cr | 0.79 Cr | 1 Cr | 2 Cr | 1 Cr | 1 Cr | 2 Cr | 1 Cr | 0.65 Cr |
| Tax % | 22.3% | 24.5% | 38.9% | 25.2% | 22.6% | 27.7% | 19.2% | 23.9% | 24.4% | 30.1% | 15.5% | 34.0% |
| Net profit | 0.40 Cr | 0.44 Cr | 0.91 Cr | 0.47 Cr | 0.62 Cr | 0.73 Cr | 2 Cr | 0.78 Cr | 0.93 Cr | 2 Cr | 0.95 Cr | 0.43 Cr |
| EPS (₹) | ₹0.23 | ₹0.25 | ₹0.10 | ₹0.03 | ₹0.04 | ₹0.04 | ₹0.09 | ₹0.02 | ₹0.08 | ₹0.10 | ₹0.05 | ₹0.01 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 29 Cr | 51 Cr | 74 Cr | 74 Cr | 80 Cr | 115 Cr | 182 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 28 Cr | 49 Cr | 71 Cr | 72 Cr | 78 Cr | 111 Cr | 176 Cr | Sign in free for the trailing twelve months |
| EBITDA | 0.67 Cr | 2 Cr | 3 Cr | 3 Cr | 2 Cr | 4 Cr | 6 Cr | Sign in free for the trailing twelve months |
| OPM % | 2.3% | 3.2% | 4.2% | 3.7% | 2.8% | 3.2% | 3.4% | Sign in free for the trailing twelve months |
| Other income | 0.05 Cr | 0.02 Cr | 0.04 Cr | 0.29 Cr | 2 Cr | 2 Cr | 2 Cr | Sign in free for the trailing twelve months |
| Interest | 0.14 Cr | 0.58 Cr | 0.54 Cr | 0.48 Cr | 0.56 Cr | 0.33 Cr | 0.73 Cr | Sign in free for the trailing twelve months |
| Depreciation | 0.19 Cr | 0.58 Cr | 1 Cr | 1 Cr | 0.87 Cr | 1 Cr | 2 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 0.39 Cr | 0.50 Cr | 1 Cr | 2 Cr | 3 Cr | 4 Cr | 6 Cr | Sign in free for the trailing twelve months |
| Tax % | 28.8% | 26.0% | 28.2% | 28.7% | 27.9% | 22.1% | 24.7% | Sign in free for the trailing twelve months |
| Net profit | 0.28 Cr | 0.37 Cr | 1 Cr | 1 Cr | 2 Cr | 3 Cr | 4 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | — | ₹0.37 | ₹1.05 | ₹1.94 | ₹0.25 | ₹0.20 | ₹0.25 | Sign in free for the trailing twelve months |
| Dividend payout % | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 0.33 Cr | 10 Cr | 10 Cr | 18 Cr | 18 Cr | 34 Cr | 34 Cr |
| Reserves | 0.64 Cr | 6 Cr | 6 Cr | 24 Cr | 25 Cr | 54 Cr | 57 Cr |
| Borrowings | 5 Cr | 7 Cr | 5 Cr | 5 Cr | 2 Cr | 2 Cr | 18 Cr |
| Other liabilities | 7 Cr | 6 Cr | 7 Cr | 12 Cr | 3 Cr | 5 Cr | 11 Cr |
| Total liabilities | 13 Cr | 28 Cr | 29 Cr | 59 Cr | 48 Cr | 95 Cr | 120 Cr |
| Fixed assets (net) | 1 Cr | 5 Cr | 6 Cr | 6 Cr | 10 Cr | 11 Cr | 26 Cr |
| CWIP | — | — | — | 0.26 Cr | 0.92 Cr | 0.29 Cr | 0 Cr |
| Investments | 6 Cr | 1 Cr | 0.70 Cr | 4 Cr | 2 Cr | 3 Cr | 2 Cr |
| Loans & advances | — | — | — | 4 Cr | 4 Cr | 13 Cr | 14 Cr |
| Inventories | 4 Cr | 5 Cr | 6 Cr | 7 Cr | 15 Cr | 24 Cr | 39 Cr |
| Trade receivables | 1 Cr | 14 Cr | 14 Cr | 21 Cr | 13 Cr | 16 Cr | 18 Cr |
| Cash & bank | 0.10 Cr | 0.24 Cr | 0.06 Cr | 0.31 Cr | 0.43 Cr | 7 Cr | 0.42 Cr |
| Other assets | 0.39 Cr | 2 Cr | 2 Cr | 17 Cr | 2 Cr | 20 Cr | 20 Cr |
| Total assets | 13 Cr | 28 Cr | 29 Cr | 59 Cr | 48 Cr | 95 Cr | 120 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | -0.67 Cr | 1 Cr | 4 Cr | -6 Cr | -4 Cr | -18 Cr | -6 Cr |
| Cash from investing | -7 Cr | -3 Cr | -2 Cr | -16 Cr | 8 Cr | -17 Cr | -16 Cr |
| Cash from financing | 7 Cr | 2 Cr | -2 Cr | 22 Cr | -4 Cr | 25 Cr | 15 Cr |
| Net cash flow | 0.03 Cr | 0.12 Cr | -0.19 Cr | 0.25 Cr | 0.12 Cr | -10 Cr | -6 Cr |
| Free cash flow (OCF − Capex) | -2 Cr | -2 Cr | 2 Cr | -8 Cr | -10 Cr | -20 Cr | -24 Cr |
Ratios
| Metric | Mar 2017 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | 8.7% | 4.9% | 9.2% | 4.4% | 7.9% | 5.2% | 5.9% |
| ROE % | 28.4% | 2.4% | 6.4% | 2.7% | 5.1% | 3.8% | 4.7% |
| Debtor days | 17 | 98 | 68 | 100 | 59 | 51 | 36 |
| Inventory days | 63 | 45 | 33 | 39 | 80 | 90 | 97 |
| Days payable | 41 | 45 | 39 | 56 | 8 | 13 | 22 |
| Cash conversion cycle | 39 | 98 | 63 | 83 | 131 | 128 | 111 |
| OCF / EBITDA % | n.m. | 70.3% | 119.8% | -201.7% | n.m. | -480.9% | -91.7% |
| OCF / EBITDA % (3 years) | — | — | — | -9.8% | -72.4% | -313.9% | -225.2% |
| Debt / equity | 5.22 | 0.43 | 0.33 | 0.12 | 0.05 | 0.02 | 0.19 |
| Current ratio | 0.73 | — | — | 2.28 | 10.74 | 12.86 | 2.72 |
| Net debt / EBITDA | 7.46 | — | — | 1.76 | 0.78 | -1.33 | 2.77 |